Solid Biosciences Inc
NASDAQ:SLDB
Solid Biosciences Inc
NASDAQ:SLDB
Price:
6.2
USD
-1.74%
Market Closed
Market Cap:
$483m
Balance Sheet
Balance Sheet Decomposition
Solid Biosciences Inc
Solid Biosciences Inc
Balance Sheet Decomposition is not available for
Solid Biosciences Inc
Solid Biosciences Inc
Balance Sheet
Solid Biosciences Inc
Solid Biosciences Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
29
|
8
|
52
|
86
|
76
|
155
|
119
|
155
|
74
|
80
|
|
| Cash Equivalents |
29
|
8
|
52
|
86
|
76
|
155
|
119
|
155
|
74
|
80
|
|
| Short-Term Investments |
27
|
30
|
17
|
36
|
8
|
0
|
89
|
58
|
50
|
69
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
2
|
6
|
3
|
4
|
15
|
6
|
6
|
8
|
|
| Total Current Assets |
56
|
40
|
71
|
129
|
86
|
159
|
223
|
220
|
130
|
157
|
|
| PP&E Net |
0
|
1
|
2
|
10
|
17
|
12
|
8
|
39
|
33
|
29
|
|
| PP&E Gross |
0
|
1
|
2
|
10
|
17
|
12
|
8
|
39
|
33
|
29
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
5
|
9
|
12
|
11
|
13
|
13
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Total Assets |
56
N/A
|
41
-27%
|
76
+88%
|
140
+83%
|
104
-26%
|
171
+65%
|
232
+36%
|
260
+12%
|
165
-37%
|
189
+14%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
3
|
5
|
4
|
7
|
3
|
5
|
3
|
2
|
4
|
|
| Accrued Liabilities |
1
|
4
|
6
|
8
|
11
|
11
|
11
|
19
|
12
|
22
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Other Current Liabilities |
12
|
0
|
0
|
0
|
0
|
10
|
8
|
0
|
0
|
3
|
|
| Total Current Liabilities |
14
|
7
|
11
|
13
|
18
|
25
|
24
|
23
|
15
|
30
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
2
|
1
|
0
|
|
| Minority Interest |
48
|
47
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
4
|
14
|
0
|
24
|
23
|
21
|
|
| Total Liabilities |
62
N/A
|
53
-13%
|
11
-79%
|
14
+27%
|
23
+63%
|
39
+67%
|
24
-38%
|
49
+101%
|
38
-21%
|
51
+34%
|
|
| Equity | |||||||||||
| Common Stock |
62
|
72
|
189
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
68
|
85
|
124
|
199
|
316
|
405
|
477
|
563
|
659
|
783
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
324
|
396
|
537
|
685
|
775
|
785
|
921
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
13
-119%
|
65
N/A
|
125
+93%
|
80
-36%
|
132
+65%
|
208
+58%
|
212
+2%
|
126
-40%
|
137
+9%
|
|
| Total Liabilities & Equity |
56
N/A
|
41
-27%
|
76
+88%
|
140
+83%
|
104
-26%
|
171
+65%
|
232
+36%
|
260
+12%
|
165
-37%
|
189
+14%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
3
|
6
|
7
|
20
|
20
|
40
|
|
Switch to:
Switch to:
See Also
Discover More
